Global Acute Lymphocytic/Lymphoblastic Leukemia Market to Grow at a Steady Rate and Post a CAGR of over 4% During 2015-2019
An in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of molecules (biologics and small molecules), and by geography (the Americas, EMEA, and APAC). The report also presents a detailed analysis of the top companies operating in the market, including Amgen, Bristol-Myers Squibb, and Novartis.
View full press release